BSF Enterprise

Bio-Sustainable Future (BSF) Enterprise is a British company that adopts an acquisition-led growth strategy in the cell-based tissue engineering sector. In May 2022 , the company successfully completed a reverse takeover of 3D Bio-Tissues Ltd. (3DBT), a Newcastle University spin-off, for GBP 1.25 million (~USD 1.56 million). 

As a wholly-owned subsidiary of BSF, 3DBT develops a patented animal-free cell growth agent (serum-free media), City-mix. This patent-protected IP can be used to culture skin, muscle, and fat cells, which it uses to develop lab-grown meat and also supplies it to other cultivated meat producers.

In February 2023 , the company announced it has produced what it claims is the world’s first 100% cultivated pork steak filet made solely with pig cells without using any plant-based scaffolds, blends, or fillers. In September 2023 , 3DBT expanded internationally with a new office in Hong Kong, aiming to introduce its flagship cell-boosting media supplement, City-Mix, to the Chinese cultivated meat market. 

Key customers and partnerships

In November 2022 , the company partnered with growth medium company Qkine, to expedite the development of cost-effective lab grown meat. Further, in December 2023 , BSF partnered with CellRev to form the joint venture (JV), Cultivated Meat Technologies Limited. The JV planned to leverage the 3DBT’s City-Mix and CellRev’s cell processing platform to scale up the production of cultivated meat.

In March 2024 , the BSF partnered with Ivy Farm Technologies, a cultivated meat company, to help the latter with fundraising, production, and broadening of cell-based meat in China.

Funding and financials

In July 2019, BSF went public on the London Stock Exchange (LSE) after a GBP 1.75 million (~USD 2.18) placement at 7.37p a share.

In September 2023 , 3D Bio Tissue (3DBT), BioBetter, and LenioBio received a total of EUR 1.8 million (~USD 1.9 million) for winning EIT Food and the Good Food Institute (GFI) Europe's Cultivated Meat Innovation Challenge. The funding was earmarked for research efforts to create cost-effective cell-cultured meat for cultivated meat production, with a focus on enhancing cell growth and yields.